• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtech stories we missed: Feb. 10, 2017

February 10, 2017 By Danielle Kirsh

[Image courtesy unsplash.com]
From Glytec partnering to beat diabetes to Biolase, Gramercy Extremity Orthopedics and more getting FDA clearances, here are 7 recent medtech stories we missed this week, but were still worth mentioning.

1. BioTime proposes public offering of common stock

Clinical-stage biotechnology company BioTech is intending to offer common stock shares in an underwritten public offering. BioTime focuses on developing and commercializing products that address degenerative diseases. It expects to offer a 30-day option to purchase up to an additional 15% of the number of shares of the common stock to underwriters. The net proceeds from the offering will go toward funding clinical trials of products in development, financing research and development programs and general working capital. Raymond James and Associates will be the sole book-running manager of the offerings.

2. Glytec inks deal with N.C. hospital system for diabetes management

Winston-Salem, N.C.–based Novant Health has partnered with Glytec to offer clinicians a set of tools and technologies to fully adopt basal-bolus insulin therapy in medical centers across the U.S. Glytec’s eGlycemic Management System (eGMS) will be in all 14 of Novant Health’s medical centers throughout North Carolina and Virginia, delivering personalized care to patients. The health systems will use the GlucoSurvelliance module of the eGMS to speed up early identification and administer insulin therapy for hospitalized patients.

3. FDA clears Bioness L300 Go rehab device

The FDA recently cleared the L300 Go System by Bioness for ankle dorsiflexion in adults and pediatric patients with foot drop or assist knee flexion. The L300 Go System is an improvement to Bioness’ previous systems, the NESS L300 Foot Drop System and NESS L300 Plus System. It is the first functional electrical stimulation system that offers 3D motion detection of gait events and muscle activation. It uses data from a 3-axis gyroscope and accelerometer and measures movement in all 3 kinetic plans. Stimulation is administered whenever it is needed during the gait cycle. The L300 Go also offers multi-channel stimulation that allows clinicians to control the amount of dorsiflexion and inversion/eversion the system transmits.

Read more on our sister site, MassDevice.

Filed Under: Business/Financial News, Diabetes, Food & Drug Administration (FDA) Tagged With: Biolase, BioTime, Geneva health Solutions, Glytec, Gramercy Extremity Orthopedics, Lombard, Nioness

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS